Kush Parmar
Insider Reports History
- Location
- San Francisco, CA
- Signature
- /s/ Kush Parmar
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Kush Parmar:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Entrada Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 2,963,066 | $26,074,980 | $8.80 | 14 Nov 2025 | By 5AM Ventures V, L.P. |
| Entrada Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 1,093,313 | $6,756,674 | $6.18 | 14 Nov 2025 | By 5AM Opportunities I, L.P. |
| Homology Medicines, Inc. | Director | Option (Right to Buy) | 18,000 | $241,560 | $13.42 | 15 Jun 2022 | Direct |
| Rallybio Corp | Director | Option (Right to Buy) | 16,500 | $29,205 | $1.77 | 15 May 2024 | Direct |
| Entrada Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 19,000 | 11 Jun 2025 | Direct | ||
| Vor Biopharma Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 16,911 | 14 Jun 2022 | Direct | ||
| Akouos, Inc. | Director, 10%+ Owner | Common Stock | 0 | $12.50 | 30 Nov 2022 | Indirect | |
| Akouos, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 0 | 01 Dec 2022 | Direct |
Insider Reports Filed by Kush Parmar
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | 14 Nov 2025 | 1 | -$1,760,000 | 4 | Director, 10%+ Owner | 18 Nov 2025, 16:36 |
| TRDA | Entrada Therapeutics, Inc. | 09 Jul 2025 | 2 | -$202,554 | 4 | Director, 10%+ Owner | 11 Jul 2025, 17:27 |
| TRDA | Entrada Therapeutics, Inc. | 27 Jun 2025 | 6 | -$866,632 | 4 | Director, 10%+ Owner | 01 Jul 2025, 20:33 |
| TRDA | Entrada Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director, 10%+ Owner | 12 Jun 2025, 08:10 |
| TRDA | Entrada Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director, 10%+ Owner | 14 Jun 2024, 16:39 |
| RLYB | Rallybio Corp | 15 May 2024 | 1 | $0 | 4 | Director | 17 May 2024, 17:05 |
| RLYB | Rallybio Corp | 02 Jan 2024 | 1 | +$47,999 | 4 | Director | 04 Jan 2024, 17:58 |
| TRDA | Entrada Therapeutics, Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 12 Jun 2023, 16:06 |
| RLYB | Rallybio Corp | 17 May 2023 | 1 | $0 | 4 | Director | 19 May 2023, 17:26 |
| RLYB | Rallybio Corp | 07 Mar 2023 | 1 | -$820,000 | 4 | Director | 09 Mar 2023, 15:39 |
| RLYB | Rallybio Corp | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 17:29 |
| /report/000110465922124136-parmar-kush-2022-11-30 | Akouos, Inc. | 30 Nov 2022 | 3 | $0 | 4 | Director, 10%+ Owner | 02 Dec 2022, 15:49 |
| /report/000110465922074826-parmar-kush-2022-06-23 | Akouos, Inc. | 23 Jun 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 27 Jun 2022, 17:02 |
| QTTB | Homology Medicines, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:05 |
| VOR | Vor Biopharma Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 16 Jun 2022, 17:09 |
| RLYB | Rallybio Corp | 03 Jun 2022 | 2 | -$1,875,000 | 4 | Director, 10%+ Owner | 07 Jun 2022, 17:03 |
| TRDA | Entrada Therapeutics, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 06 Jun 2022, 16:01 |
| RLYB | Rallybio Corp | 24 May 2022 | 1 | $0 | 4 | Director | 26 May 2022, 20:08 |
| RLYB | Rallybio Corp | 23 May 2022 | 2 | -$1,300,000 | 4 | Director, 10%+ Owner | 25 May 2022, 18:34 |
| RLYB | Rallybio Corp | 08 Feb 2022 | 2 | -$2,740,500 | 4 | Director | 10 Feb 2022, 17:22 |
| RLYB | Rallybio Corp | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 19:38 |
| VOR | Vor Biopharma Inc. | 16 Nov 2021 | 2 | -$5,059,802 | 4 | Director, 10%+ Owner | 18 Nov 2021, 19:10 |
| TRDA | Entrada Therapeutics, Inc. | 02 Nov 2021 | 11 | +$5,000,000 | 4 | Director, 10%+ Owner | 05 Nov 2021, 08:49 |
| TRDA | Entrada Therapeutics, Inc. | 28 Oct 2021 | 0 | $0 | 3/A | Director, 10%+ Owner | 05 Nov 2021, 08:48 |
| TRDA | Entrada Therapeutics, Inc. | 28 Oct 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 01 Nov 2021, 21:48 |
| RLYB | Rallybio Corp | 29 Jul 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 29 Jul 2021, 19:38 |
| RLYB | Rallybio Corp | 28 Jul 2021 | 8 | +$7,999,992 | 4 | Director | 04 Aug 2021, 21:19 |
| /report/000110465921085766-parmar-kush-2021-06-24 | Akouos, Inc. | 24 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 25 Jun 2021, 16:38 |
| QTTB | Homology Medicines, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 17:40 |